Utah Medical Products reported a strong fourth quarter in 2019, with a 21.3% increase in revenues and a 28.5% increase in net income compared to the same period in 2018. The company benefited from direct sales of the Filshie Clip System and growth in OEM product sales. Earnings per share also saw a significant increase, reflecting the company's improved profitability.
Revenue increased by 21.3% due to higher U.S. sales of the Filshie Clip System and OEM product sales.
Gross profit increased by 28%, reflecting improved sales and productivity.
Operating income increased by 9.6%, driven by higher gross profit exceeding amortization expenses.
Net income increased by 28.5% due to increased sales and a favorable tax estimate adjustment.
Management believes overall UTMD year 2020 USD-denominated consolidated revenues are likely to not increase more than in the range of low single percentage digits.
Analyze how earnings announcements historically affect stock price performance